Biotechnology Directory - Companies - Abbott Laboratories Discovering, developing and marketing innovative health care solutions across the spectrum of health care.
- Abeille Pharmaceuticals Developing pharmaceutical products with a focus on improving existing drugs or optimizing future drug candidates.
- Ablynx Biopharmaceutical company engaged in the discovery and development of Nanobodies to treat a range of serious human diseases. Nanobodies are a novel class of antibody-derived therapeutic proteins.
- Acrongenomics A publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the Life Sciences sector.
- Adolar Committed to the development of novel analgesics and pain-related therapeutics based upon recent advances in proprietary medicinal chemistry and recombinant opioid receptor technology.
- Aeolus Pharmaceuticals Developing a new class of catalytic antioxidant compounds.
- Alexza Pharmaceuticals Proprietary products for acute and intermittent condistions.
- Allergan
- Allergy information Schering
- Allergy Therapeutics A European-based speciality pharmaceutical company focused upon the treatment and prevention of allergy.
- Alliance Pharmaceutical Focusing on the application of scientific discoveries that can be developed into innovative drug products.
- AlphaRx A pharmaceutical company specializing in the formulation of therapeutic products using proprietary drug delivery technologies; core competent is in the development of novel drug formulations for compounds that are otherwise insoluble or poorly soluble in water.
- Alphavax Uses a specialized viral vector system to make alphavirus replicon vaccines called alphavaccines, which have shown excellent protection in multiple models for infectious disease and cancer.
- ALZA Focussing on the development of drug delivery-based pharmaceuticals.
- Amaxa Biosystems A research-oriented, rapidly expanding biotech company focusing on the development of innovative gene transfer technologies.
- Ambryx Biotechnology Discovering and developing naturally occurring bioactive peptides into therapeutics to treat cancer and obesity.
- American Home Products Vaccines, prescription drugs, biotechnology, agricultural and animal healthcare products.
- Amgen
- Amgen Germany
- Amorfix Life Sciences A theranostics company focused on the diagnosis and treatment of neurodegenerative diseases, where aggregated misfolded proteins (AMP) are prevalent. These include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).
- AmpliMed A comprehensive cancer drug development company.
- Amylin Pharmaceuticals Focused on developing novel medicines for treating metabolic disorders.
- Angiotech Pharmaceuticals Development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug, paclitaxel.
- Antigenics Developing personalized immunotherapeutics and treatments for cancers, infectious diseases and autoimmune disorders.
- Antisoma Aiming to develop tumour targeted products that provide safer and more effective methods of diagnosing and treating cancer.
- Aphios Developing enhanced natural therapeutics and biologics for health maintenance, disease prevention and the treatment of human diseases with a focus on infectious diseases, oncology and quality-of-life (QOL) medicines.
- Apoxis Develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis, or cell death.
- Applied Molecular Evolution Discovering, developing and commercializing optimized human biotherapeutics.
- Arcadia Biosciences Developing and commercializing biotechnologies that make agriculture more economically and environmentally sustainable.
- Ardais A clinical genomics company applying actual human disease as the discovery model in pharmaceutical research.
- Arena Developing a broad pipeline of compounds that act on G protein-coupled receptors, or GPCRs. The company focuses on the discovery, development, and commercialization of drugs in four major therapeutic areas: metabolic, cardiovascular, inflammatory, and central nervous system diseases.
- Ariad Pharmaceuticals Discovery and development of proprietary platform technologies and small-molecule therapeutic products based on gene regulation and signal transduction.
- Ark Therapeutics A specialist healthcare group with operations in the UK and Finland; focuses on areas of high unmet clinical need in vascular disease and cancer.
- AstraZeneca Pharmaceutical company with business is focused on seven major therapeutic areas: cardiovascular, central nervous system, gastrointestinal, infection, oncology, pain control and anaesthesia, and respiratory.
- AVAX Technologies Oncology treatments.
- Aventis Biotechnological custom process development, custom manufacturing and product development. Pharma and agriculture.
- Avigen Development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited and acquired diseases.
- Avonex Interferon beta-1a information.
- Baxter
- Bayer
- Berlex Betaseron® Multiple Sclerosis Resource Center
- Beyond Genomics Applying systems biology to drug discovery and development; proprietary BioSystematics and BioSystem marker technology.
- Bio Balance A Biotechnology/Pharmaceutical Discovery Company.
- Bio-Bridge Science Developing vaccines and drugs to treat human diseases (China).
- Biogen Biotechnology company principally engaged in developing genetically engineered human pharmaceuticals.
- Biological Mimetics Scientific services including virology, gene expression, molecular biology, and immunology for academic, institutional, and pharmaceutical laboratories.
- BioPartners A biopharmaceutical company specialising in accelerating the global development and commercialisation of high quality recombinant biopharmaceutical products.
- Biopharmacopae Design International Identification and development of new molecules with drug-like properties from natural sources using a proprietary library and HTS adapted for natural extracts. Indications under development: new cancer approach and skin diseases.
- BioProtein Technologies Dedicated to the production of therapeutic proteins in the milk of transgenic rabbits.
- Biopure A privately held biopharmaceutical company that develops, manufactures and markets oxygen-carrying hemoglobin solutions, or "oxygen therapeutics," for use in veterinary and human medicine.
- biotica A pharmaceutical company focused on the discovery and development of novel anti-cancer drugs through synthetic biology of natural products known as polyketides.
- Biovail A full-service pharmaceutical company that applies its proprietary drug delivery technologies in developing "oral controlled-release" products.
- Biovertis Discovers and develops novel antibiotics to combat the increasing threat of infective microbes that are resistant to available therapies.
- Biovest Develops personalized immunotherapies for life threatening cancers of the blood system.
- BioXell Developing new therapeutic candidates in the areas of urology and inflammation, using its unique expertise in VD3 chemistry and biology
- Boehringer Ingelheim Partnerships for contract manufacturing of biopharmaceuticals in mammalian cell culture and microorganisms.
- Boehringer Mannheim As of March 1998, Roche Molecular Biochemicals.
- Bristol-Myers Squibb Medicines, nutritionals and medical devices, worldwide.
- Cangene Developing , manufacturing, and commercializing of specialty hyperimmune plasma and biotechnology products.
- Caprion Technology for the quantitative profiling of biological systems at the level of proteins.
- Cara Therapeutics An emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation.
- Cardiome Tissue targeted cardiac drugs.
- Cell Genesys Focused on the development and commercialization of gene therapies to treat cancer and other major, life-threatening diseases.
- Cell Therapeutics, Inc. Focussing on the discovery, development, and commercialization of small molecule drugs for the treatment of cancer and inflammatory and immune diseases.
- CEL-SCI Corporation Developments in natural immunotherapy.
- Ceragenix Pharmaceuticals Discovery, development and commercialization of products in the fields of dermatology, oncology and infectious diseases.
- Ceregene Discovery and development of novel genetic therapeutics for the treatment of neurological disorders.
- ChemGenex Pharmaceuticals Focused on developing novel targeted medicines for chronic diseases which have a genetic component exploitable as a drug target or where genetic differences between patients offers the opportunity to stratify patients for better clinical outcomes; using genomic and proteomic technologies from discovery through clinical development.
- Chiron Combining diagnostic, vaccine and therapeutic strategies against many diseases. cGMP contract manufacturing services for large-scale microbial fermentation, recovery and downstream purification.
- Chrysalon Specialising in pharmaceutical researchanddevelopment, and particularly in the design and optimisation of small organic molecules with therapeutic potential.
- Chugai Pharma Europe
- Chugai Pharmaceutical Co.
- Ciba See Novartis
- Ciba Specialty Chemicals Discovery, manufacture and marketing of innovative specialty chemicals.
- Cogent Neurosciences Focus is in the area of ischemic brain insult: stroke, traumatic brain injury and epilepsy.
- Coley Pharmaceutical Group Discovers and develops investigational TLR (Toll-like receptors), a class of drugs that direct the immune system to treat chronic disease.
- ConjuChem Creating novel, next-generation medicines using unique, long-acting therapeutic peptides.
- Corixa Ttreating and preventing autoimmune disease, cancer and infectious disease by understanding and directing the immune system.
- Cytogenix A biopharmaceutical company that develops and markets innovative compounds and services based on its proprietary gene regulating technology; has also developed a cell free process for synthesizing DNA.
- Cytos Pharmaceuticals Developing commercially important pharmaceutical products relating to the potential therapeutic use of the essential amino acid L-histidine.
- deCODE genetics Iceland
- Dendreon Working with the new class of therapy known as Active Cellular Immunotherapies (ACIs).
- Dermik Laboratories
- Destiny Pharmaceuticals Conducts proprietary and contract research within the pharmaceutical R&D business sector; identifies and develops patented therapeutic pharmaceutical technologies for exploitation by the pharmaceutical industry.
- diaDexus Discovery and validation of novel genomic biomarkers for the detection and treatment of disease.
- DNA Phenomics Engaged in the discovery and production of genomic-based personalized medical solutions.
- Do-Coop Producing a novel proprietary water-based nanotechnology, NeoWater, as an enabling platform for research, diagnostics, biotech and pharma companies
- domantis A biotechnology company engaged in the discovery and development of a new generation of proprietary protein products that incorporate the biological benefits and commercial advantages of both large proteins and small molecules.
- Draxis Health Veterinary pharmaceuticals and DRAXIMAGE, engaged in the research, development, manufacture, marketing and sale of radiopharmaceuticals for diagnostic and therapeutic purposes.
- Durect Products to treat chronic debilitating disease, and technologies that enable biotechnology products.
- Dynavax Discovers and develops TLR-9 (Toll-like receptors) based products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases.
- DyoDelta Biosciences Specializing in supporting biotech and pharma companies in corporate partnerships.
- Ecopia Biosciences New antibacterial, antifungal and anticancer agents.
- Eden Biodesign Design and development of biopharmaceutical medicines.
- Elan Focused on the discovery, development and marketing of products in neurology, pain management and autoimmune diseases.
- Eli Lilly and Company
- Emergent BioSolutions A biologics company focused on the research, development and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction.
- Enzo Therapeutics Developing medicines based on genetic and immune regulation to combat infectious diseases, autoimmune-based diseases and cancers.
- Erimos Biotechnology company focused on the discovery, development and commercialization of small molecule drugs to treat HIV and cancer.
- Eskayef Pharmaceutical company in Bangladesh engaged in the manufacture and marketing of therapeutic drugs, bulk pellets and animal health and nutrition products.
- EURAND Specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies.
- Euroscreen Drug discovery company focussed on "de-orphanizing" G protein-coupled receptors (GPCR's).
- ExonHit Therapeutics Develops, applies and markets specific qualitative gene profiling technology for diagnostic, predictive toxicology and therapeutic purposes.
- Fujisawa Healthcare USA
- Genelabs Engaged in the discovery and development of a new class of pharmaceutical products that selectively regulate gene expression and the development of GL701, a proprietary hormone treatment for systemic lupus erythematosus (SLE or lupus).
- Genentech
- Geneohm Uses the flow of electric current through DNA to detect genetic mutations.
- Genetronics Biomedical "A drug delivery company specializing in developing technology and hardware which potentially will allow physicians more efficiently and cost-effectively to deliver life-saving drugs or beneficial genes to patients with catastrophic illnesses, including cancer and heart disease."
- GENFIT Biopharmaceutical company focused on discovery and development of innovative therapies to reduce cardiometabolic risk.
- GenPhar A biopharmaceutical company with focus in viral diagnostics, vaccines, and cancer therapy.
- Gen-Probe Developing, manufacturing, and commercializing diagnostic products based on a patented DNA probe technology.
- Genzyme Specialized pharmaceutical intermediates and fine chemicals, custom development of small molecule pharmaceuticals.
- Gilead Sciences Focused on infectious diseases and oncology.
- GlaxoSmithKline
- GMP Genetics Genetics testing technologies.
- Graffinity Lead discovery and development of small molecule pharmaceuticals.
- Helicon Therapeutics Drug discovery for disorders of the memory.
- Helix BioPharma Focused on the discovery and development of innovative anti-cancer therapeutics.
- Hoechst Internet forum.
- HUM-MOLGEN Registry of Biotechnology Companies
- Iconix Pharmaceuticals Chemogenomics platform includes an integrated database architecture to bridge genomics and drug design, novel bio- and chemoinformatics software, and advanced expression array and cellular assay development capabilities.
- ImClone Systems Development of novel treatments for cancer and cancer-related disorders.
- ImmunoGen Focused on Tumor-Activated Prodrugs for colorectal cancer, small-cell lung cancer and other aggressive malignancies.
- Immusol Applying a proprietary drug target discovery technology called Inverse Genomics® to identify therapeutic targets in biological systems.
- Impotence information Pharmacia & Upjohn
- Intronn Technology for gene therapy that exploits the differential gene expression between normal and diseased cells.
- Ixion Biotechnology Discovering and developing breakthrough cell-based therapies for insulin-dependent diabetes.
- Jazz Pharmaceuticals Products for patients and healthcare professionals in areas with unmet therapeutic needs.
- Johnson & Johnson
- Juvaris BioTherapeutics Developing therapeutic vaccines for cancer and infectious diseases using its novel technology platform of cationic lipids and non-coding DNA complexes.
- Kosan Biosciences Proprietary technologies to develop drug candidates from an important class of natural product compounds known as polyketides, a source of many pharmaceuticals, including antibiotics, anticancer drugs, cholesterol-lowering drugs, immunosuppressants and other therapeutics.
- Labopharm Reformulating existing drugs to deliver with controlled-release technology.
- Laboratorios Syva Producing and marketing veterinary pharmaceuticals and biologicals since 1941.
- Lexrite Engineering antibody payload deliverysystems for targeted cancer therapeutics.
- Lifespan Developing heparin tests based on a novel new protein.
- Lundbeck Focusing solely on the treatment of diseases of the central nervous system.
- MacroGenics Develops, manufactures and commercializes biotechnology products including immunotherapeutics for cancer, infectious diseases, and autoimmune disorders.
- Magistral Biotech Research, development, manufacturing and marketing of natural health products whose therapeutic effects have been subject to scientifically review.
- MannKind A biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.
- Maxim Pharmaceuticals A bio-pharmaceutical company with a diverse pipeline of therapeutic candidates for life-threatening cancers, hepatitis and other liver diseases.
- Medco Research
- Medeva Develops, manufactures and markets prescription pharmaceutical products. Focused principally on central nervous system; respiratory; vaccines; hospital products; gastrointestinal; and dermatology.
- MediciNova A specialty pharmaceutical company focused on acquiring and accelerating the global development and commercialization of innovative pharmaceutical products.
- Medicis Pharmaceutical Corp.
- Medicure A cardiovascular drug discovery and development company.
- MediGene Dedicated to the discovery, development and commercialization of novel molecular therapies for the treatment of major, life-threatening diseases.
- MediQuest Therapeutics Discovery and development efforts focus primarily on inflammatory/infectious skin diseases and conditions.
- Memory Pharaceuticals Neuropharmaceutical development.
- Merck MSD ... Merck Sharp & Dohme
- MethylGene Focus in the areas of cancer, antibiotic resistance, and other diseases such as diabetes, Huntington's and inflammation.
- Microbia Harnessing the regulatory circuitry that governs microbial physiology and metabolism to develop new anti-infective therapeutics.
- Micrologix Biotech Developing treatment options for life-threatening diseases caused by multidrug-resistant bacteria.
- Mikhaus Laboratories A clinical stage biopharmaceutical company focused on therapeutics for chronic diseases.
- Milagen Engaged in the discovery, validation and development of pharmaceutical products.
- Millenium Pharmaceuticals Product development using genomics methods.
- Mixture Sciences Specializes in biomedical research and drug discovery; uses a combination of proprietary and in-licensed technologies for the discovery of therapeutic and diagnostic candidates for the treatment of HIV/AIDS, cancer, diabetes, multiple sclerosis, and infectious diseases, including Lyme Disease.
- Molecular Nanosystems Research and development of nanotube-based products using site-selective chemical vapor deposition technology.
- MorphoSys Focussing on the development of fully human recombinant antibodies for use in therapeutic, diagnostic and research applications.
- Morphotek A biotechnology company focused on developing genetically diverse organisms for agricultural, life science, and pharmaceutical use.
- Myriad A biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies.
- NanoViricides Nanotechnology applied to target anti-viral therapeutics.
- Nektar Therapeutics Therapies that fill critical, unmet medical needs; drug delivery technology.
- NeoGenesis Chemical Genetics strategy that utilizes drug-like, small molecule ligands very early in the discovery process to empirically determine and prioritize the biological utility and drugability of poorly characterized, disease-associated proteins.
- NeoRx Cancer therapeutic development company with technologies for targeted delivery of therapeutic agents, including radiopharmaceuticals, directly to sites of disease.
- Neurochem Focused on the development of therapeutic treatments and diagnostic tools for central nervous system and amyloid related diseases.
- NeXstar Pharmaceuticals
- Novartis
- Novo Nordisk A/S Pharmaceutical and industrial enzyme products.
- NUCRYST Development through use of noble metal nanocrystalline pharmaceutical and medical device technologies.
- Nutra Pharma A biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases.
- OPTIME Therapeutics Develops non-viral vectors for gene therapy; based on liposomes, protein-nanospheres and kationic lipids develops novel, fourth-generation gene-vectors.
- OREXIGEN Therapeutics A biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system disorders, with an initial focus on obesity.
- Organon The largest Dutch research-based pharmaceutical company and the largest pharmaceutical business unit of Akzo Nobel.
- Osiris Therapeutics Developing and commercializing cellular therapies based on stem cells isolated from readily available adult bone marrow.
- Otsuka Pharmaceutical Co.
- Oxigene developing novel small-molecule therapeutics to treat cancer and eye diseases; focus is on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.
- OxThera Cell and enzyme based proprietary technologies to treat and prevent hyperoxaluria and kidney stones.
- Pacific Edge Biotechnology Biomedical company developing novel diagnostic and therapeutic products to manage cancer and other diseases (new Zealand).
- Paradigm Genetics A biotechnology company applying its proprietary systems biology platform to the discovery of drugs and agrichemicals
- Pfizer Includes Agouron, Parke-Davis, Monsanto,Pharmacia Upjohn
- Phares Drug Delivery AG A drug delivery company specializing in the screening and formulation of poorly water soluble compounds to maximize bioavailability.
- Phoqus A drug delivery company providing a range of drug delivery systems based on electrostatic dry powder deposition technology.
- PhRMA Pharmaceutical Research and Manufacture of America ... excellent source of information concerning pharmaceutical development.
- PLIVA Global generics producer.
- PLIVA-Lachema Focuses on the research, development and production of medical products used in the treatment of serious diseases - cancer, cardiovascular diseases or viral infections.
- Procter & Gamble Health Care
- Profos AG Resource for work-force solutions to the universities, government laboratories, biotechnology and pharmaceutical companies.
- Protherics Developing and licensing products for niche markets.
- Purdue Pharma Research, development, marketing, sales, distribution and licensing of prescription pharmaceuticals, over the counter medicines and hospital products.
- ReceptoPharm A biotech company applying bioscience to snake venom neurotoxins like cobratoxin for biopharmaceuticals drug discovery investments, biotherapeutics and neurological therapeutics for hiv, aids, ms, mg therapy pharmaceuticals.
- Receptor BioLogix Developing a new class of receptor modulator called Intron Fusion Proteins to treat cancer, autoimmune, metabolic and other diseases.
- Regeneron Pharmaceuticals Develops medicines for the treatment of serious medical conditions.
- Retroscreen Ltd. Screening for new antiviral drugs on behalf of customers, clinical trials, development of intellectual property, and joint research agreements.
- Roche
- Roxane Pain Institute
- Samaritan Pharmaceuticals Product-driven biopharmaceutical company dedicated to saving lives by incubating breakthrough discovery for Alzheimer's, cancer, high cholesterol, HIV and Parkinson's.
- Sandoz
- Sankyo Pharma U.S. subsidiary of Tokyo-based Sankyo
- SBC Schweitzer Biotech Provider of technologies to the aquatic and poultry vaccine industries; cooperates with academia, government institutions and industry to explore opportunities and develop patentable technologies.
- Sertanty A drug discovery technology company that uses advanced empirical data and computational techniques to discover novel small molecules that can be transformed into orally-available drugs.
- Shimoda Biotech Innovates therapeutic compounds in proprietary drug delivery systems, with cancer research as a primary focus.
- Sierra Sciences A biotechnology company seeking a medicine to prevent and/or reverse cellular senescence, an underlying cause of many diseases, particularly the diseases of aging.
- Signal Pharmaceuticals An integrated target and drug discovery company focused on identifying new classes of small molecule drugs that regulate genes and the production of disease-causing proteins.
- Sirna Therapeutics Rights to over 300 issued, allowed or pending patents relating to nucleic acid technology and RNAi; developing of RNAi-based therapeutics.
- SLIL Biomedical Engaged in the discovery and development of a range of new cancer drugs, based on its world-leading position in the field of polyamine analogs and its proprietary Tumor Targeting and Delivery (TTD) technology.
- SmithKline Beecham
- Sonus Pharmaceuticals Focused on development of therapeutics that may offer improved administration, safety, tolerability, and effectiveness for the treatment of cancer and related conditions.
- Starpharma Drug development through dendrimer-based nanotechnology.
- Stryker Biotech Developing new products for bone repair based on the Bone Morphogenetic Protein, recombinant human Osteogenic Protein-1 (rhOP-1).
- SUGEN Developing new drugs to target signal transduction pathways inside the body's cells.
- Supernus Pharmaceuticals Product development and oral drug delivery.
- Symbollon A specialty pharmaceutical company focused on the development and commercialization of proprietary drugs based on its molecular iodine technology.
- Synthetic Genomes Developing scientific processes to enable industry to design and test desired genetic modifications
- Syrrx A drug discovery company based on rational drug design.
- Targeted Genetics Discovery and development of molecular medicines to prevent or treat acquired, inherited and infectious diseases that have significant unmet medical need.
- Tassa Pharmaceuticals Developing next generation anti-infective compounds for treatments for tenacious and drug resistant strains of bacteria.
- Tengion A biotech company in the field of regenerative medicine.
- Tensor Biosciences Brain-on-a-Chip™ technology combines the automated real-time analysis of electrical activity in the brain with advanced pattern analysis and classification software. Tensor is using these tools to identify therapeutics for psychiatric and neurodegenerative disorders.
- TopoTarget Objective is to develop and market novel pharmaceuticals and to identify new indications for existing compounds.
- Tularik Development of medicines that regulate gene expressions.
- U3 Pharma AG Biotherapeutic products to treat cancer and hyperproliferative diseases.
- VaxGen A biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease.
- Vertex Pharmaceutical Focused on the discovery, development and commercialization of breakthrough drugs for a range of serious diseases.
- Vertex Pharmaceuticals Small molecule drug candidates in development targeting high unmet medical needs across a range of therapeutic areas; principally focused on viral diseases, inflammation, autoimmune diseases, genetic disorders and cancer.
- Vical Research and develop biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
- Victhom Human Bionics Develops orthotics and prosthetics, neurotechnology with neurosensor and neurostimulator implants, and active biomaterials.
- VISCUM AG A biopharmaceutical company that develops drugs from various natural sources; focuses on rapid preclinical and clinical development as well as on registration and market launch of novel therapeutic agents mainly in the oncological field.
- Viventia Biotech Developing innovative therapeutics based upon the human immune response to cancer.
- Xoma Develops biopharmaceuticals targeting cancer, immunological disorders and infectious diseases.
- YORK PHARMA Objective is the acquisition, development and commercialisation of prescription dermatological products.
- Zila Focused on oral care.
- ZymoGenetics Leverages its expertise in bioinformatics and biology to discover novel therapeutic proteins.
